Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 10;10(10):1689.
doi: 10.3390/vaccines10101689.

Comprehensive Highlights of the Universal Efforts towards the Development of COVID-19 Vaccine

Affiliations
Review

Comprehensive Highlights of the Universal Efforts towards the Development of COVID-19 Vaccine

Riyaz Ahamed Shaik et al. Vaccines (Basel). .

Abstract

The world has taken proactive measures to combat the pandemic since the coronavirus disease 2019 (COVID-19) outbreak, which was caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). These measures range from increasing the production of personal protective equipment (PPE) and highlighting the value of social distancing to the emergency use authorization (EUA) of therapeutic drugs or antibodies and their appropriate use; nonetheless, the disease is still spreading quickly and is ruining people's social lives, the economy, and public health. As a result, effective vaccines are critical for bringing the pandemic to an end and restoring normalcy in society. Several potential COVID-19 vaccines are now being researched, developed, tested, and reviewed. Since the end of June 2022, several vaccines have been provisionally approved, whereas others are about to be approved. In the upcoming years, a large number of new medications that are presently undergoing clinical testing are anticipated to hit the market. To illustrate the advantages and disadvantages of their technique, to emphasize the additives and delivery methods used in their creation, and to project potential future growth, this study explores these vaccines and the related research endeavors, including conventional and prospective approaches.

Keywords: COVID-19; clinical trials; coronavirus; development; vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Various types of coronavirus vaccines and their examples.
Figure 2
Figure 2
The developmental progress of the Moderna mRNA-1273 vaccine.

References

    1. Anand U., Jakhmola S., Indari O., Chandra Jha H., Chen Z.S., Tripathi V., Pérez de la Lastra J.M. Potential therapeutic targets and vaccine development for COVID-19 management: A review on the recent update. Front. Immunol. 2021;12:2454. doi: 10.3389/fimmu.2021.658519. - DOI - PMC - PubMed
    1. Izda V., Jeffries M.A., Sawalha A.H. COVID-19: A review of therapeutic strategies and vaccine candidates. Clin. Immunol. 2021;222:108634. doi: 10.1016/j.clim.2020.108634. - DOI - PMC - PubMed
    1. Shahzamani K., Mahmoudian F., Ahangarzadeh S., Ranjbar M.M., Beikmohammadi L., Bahrami S., Mohammadi E., Esfandyari S., Alibakhshi A., Javanmard S.H. Vaccine design and delivery approaches for COVID-19. Int. Immunopharmacol. 2021;100:108086. doi: 10.1016/j.intimp.2021.108086. - DOI - PMC - PubMed
    1. Mellet J., Pepper M.S. A COVID-19 vaccine: Big strides come with big challenges. Vaccines. 2021;9:39. doi: 10.3390/vaccines9010039. - DOI - PMC - PubMed
    1. Kaur R.J., Dutta S., Bhardwaj P., Charan J., Dhingra S., Mitra P., Singh K., Yadav D., Sharma P., Misra S. Adverse Events Reported from COVID-19 Vaccine Trials: A Systematic Review. Indian J. Clin. Biochem. 2021;36:427–439. doi: 10.1007/s12291-021-00968-z. - DOI - PMC - PubMed